{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:54:10Z","timestamp":1791431650884,"version":"4.3.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ANRF\/PAIR\/2025\/000008"],"award-info":[{"award-number":["ANRF\/PAIR\/2025\/000008"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02081-2","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:54:06Z","timestamp":1774486446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring gut microbiome alterations and hormonal imbalances in polycystic ovary syndrome: insights from a comparative study"],"prefix":"10.1186","volume":"19","author":[{"given":"Jalpa","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiral","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushikesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"1","key":"2081_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-021-00879-w","volume":"14","author":"H Chaudhary","year":"2021","unstructured":"Chaudhary H, Patel J, Jain NK, Joshi R. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis. J Ovarian Res. 2021;14(1):1\u201321. Available from: https:\/\/doi.org\/10.1186\/s13048-021-00879-w.","journal-title":"J Ovarian Res"},{"key":"2081_CR2","doi-asserted-by":"publisher","first-page":"108949","DOI":"10.1016\/j.reprotox.2025.108949","volume":"135","author":"J Patel","year":"2025","unstructured":"Patel J, Chaudhary H, Panchal S, Joshi R. Plasticizer exposure and reproductive dysfunction: Assessing bisphenol A and phthalate esters impact on ovarian reserve in women with PCOS-associated infertility. Reprod Toxicol. 2025;135(February):108949. Available from: https:\/\/doi.org\/10.1016\/j.reprotox.2025.108949.","journal-title":"Reprod Toxicol"},{"issue":"2","key":"2081_CR3","first-page":"90","volume":"4","author":"P Radha","year":"2016","unstructured":"Radha P, Devi RS, Madhavi J. Comparative study of prevalence of polycystic ovarian syndrome in rural and urban population. J Adv Med Dent Scie Res. 2016;4(2):90\u20135.","journal-title":"J Adv Med Dent Scie Res"},{"issue":"4","key":"2081_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpag.2011.03.002","volume":"24","author":"R Nidhi","year":"2011","unstructured":"Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of Polycystic Ovarian Syndrome in Indian Adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223\u20137. Available from: https:\/\/doi.org\/10.1016\/j.jpag.2011.03.002","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2081_CR5","doi-asserted-by":"crossref","unstructured":"Joshi R, Patel J, Chaudhary H Comparing the Metabolomic Landscape of Polycystic Ovary Syndrome within Urban and Rural Environments. 2025. Available from: https:\/\/figshare.com\/articles\/dataset\/_b_Comparing_the_Metabolomic_Landscape_of_Polycystic_Ovary_Syndrome_within_Urban_and_Rural_Environments_b_\/28891628.","DOI":"10.1038\/s43856-025-00985-6"},{"key":"2081_CR6","doi-asserted-by":"publisher","first-page":"108562","DOI":"10.1016\/j.reprotox.2024.108562","volume":"125","author":"J Patel","year":"2024","unstructured":"Patel J, Chaudhary H, Panchal S, Joshi T, Joshi R. Endocrine-disrupting chemicals and hormonal profiles in PCOS women: a comparative study between urban and rural environment. Reprod Toxicol. 2024;125(February):108562. Available from: https:\/\/doi.org\/10.1016\/j.reprotox.2024.108562.","journal-title":"Reprod Toxicol"},{"key":"2081_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-024-01548-1","author":"J Patel","year":"2024","unstructured":"Patel J, Chaudhary H, Panchal S, Parekh B, Joshi R. Connecting bisphenol a exposure to pcos: findings from a case-control investigation. Reprod Sci. 2024;(0123456789). Available from: https:\/\/doi.org\/10.1007\/s43032-024-01548-1.","journal-title":"Reprod Sci"},{"issue":"1","key":"2081_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-023-01654-0","volume":"16","author":"H Chaudhary","year":"2023","unstructured":"Chaudhary H, Patel J, Jain NK, Panchal S, Laddha N, Joshi R. Association of FTO gene variant rs9939609 with polycystic ovary syndrome from Gujarat, India. BMC Med Genomics. 2023;16(1):1\u20139.","journal-title":"BMC Med Genomics"},{"key":"2081_CR9","doi-asserted-by":"crossref","unstructured":"Poojara L, Acharya DK, Patel J, Rawal RM. Gut\u2013brain axis: role of the gut microbiome on human health. Microbiome-Gut-Brain Axis. 2022;187\u2013211.","DOI":"10.1007\/978-981-16-1626-6_8"},{"issue":"2","key":"2081_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clim.2015.05.013","volume":"159","author":"E G\u00fclden","year":"2015","unstructured":"G\u00fclden E, Wong FS, Wen L. The gut microbiota and type 1 diabetes. Clin Immunol . 2015;159(2):143\u201353. Available from: https:\/\/doi.org\/10.1016\/j.clim.2015.05.013.","journal-title":"Clin Immunol"},{"issue":"1","key":"2081_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-39168-5","volume":"13","author":"J Patel","year":"2023","unstructured":"Patel J, Chaudhary H, Rajput K, Parekh B, Joshi R. Assessment of gut microbial \u03b2-glucuronidase and \u03b2-glucosidase activity in women with polycystic ovary syndrome. Sci Rep. 2023;13(1):1\u20138. Available from: https:\/\/doi.org\/10.1038\/s41598-023-39168-5.","journal-title":"Sci Rep"},{"key":"2081_CR12","doi-asserted-by":"publisher","unstructured":"Chen KL, Madak-Erdogan Z. Estrogen and Microbiota Crosstalk: Should We Pay Attention? Trends Endocrinol Metab [Internet]. 2016;27(11):752\u20135. Available from: https:\/\/doi.org\/10.1016\/j.tem.2016.08.001.","DOI":"10.1016\/j.tem.2016.08.001"},{"key":"2081_CR13","doi-asserted-by":"publisher","unstructured":"Yurtda\u015f G, Akdevelio\u011flu Y. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota. J Am Coll Nutr [Internet]. 2020;39(4):371\u201382. Available from: https:\/\/doi.org\/10.1080\/07315724.2019.1657515.","DOI":"10.1080\/07315724.2019.1657515"},{"issue":"4","key":"2081_CR14","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2017-02153","volume":"103","author":"PJ Torres","year":"2018","unstructured":"Torres PJ, Siakowska M, Banaszewska B, Pawelczyk L, Duleba AJ, Kelley ST, et al. Gut Microbial Diversity in Women with Polycystic Ovary Syndrome Correlates with Hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2081_CR15","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1039\/C9FO02554E","volume":"11","author":"Y He","year":"2020","unstructured":"He Y, Wang Q, Li X, Wang G, Zhao J, Zhang H, et al. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota. Food Funct. 2020;11(6):5192\u2013204.","journal-title":"Food Funct"},{"issue":"2","key":"2081_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1055\/a-1081-2036","volume":"80","author":"X Zhao","year":"2020","unstructured":"Zhao X, Jiang Y, Xi H, Chen L, Feng X. Exploration of the Relationship between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): A Review. Geburtshilfe Frauenheilkd. 2020;80(2):161\u201371.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2081_CR17","doi-asserted-by":"crossref","unstructured":"Senthilkumar H, Arumugam M. Gut microbiota: a hidden player in polycystic ovary syndrome. 2025;7.","DOI":"10.1186\/s12967-025-06315-7"},{"key":"2081_CR18","doi-asserted-by":"crossref","unstructured":"Zhao M, Chen D, Hu X, Xie C, Xu L, Zhou F. Gut-ovary axis in polycystic ovary syndrome: mechanistic insights and gut microbiota- targeted therapeutic strategies. 2025;(November):1\u201311.","DOI":"10.3389\/fendo.2025.1684492"},{"key":"2081_CR19","doi-asserted-by":"crossref","unstructured":"Cai M, Ni Z, Yao Y, Yu J, Yu C, Zhou L et al. characteristics of gut microbiota and its relationship with serum sex hormones in non-obese polycystic ovary syndrome patients with insulin resistance. 2022;1\u201314. Available from: https:\/\/www.researchsquare.com\/article\/rs-1304673\/latest.pdf.","DOI":"10.21203\/rs.3.rs-1304673\/v1"},{"key":"2081_CR20","doi-asserted-by":"crossref","unstructured":"Feng X, Hua R, Zhang W, Liu Y, Luo C, Li T et al. Comparison of the gut microbiome and resistome in captive African and Asian elephants on the same diet. Front Vet Sci. 2023;10(2).","DOI":"10.3389\/fvets.2023.986382"},{"issue":"21","key":"2081_CR21","first-page":"2957","volume":"27","author":"SL Salzberg","year":"2011","unstructured":"Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Tanja Mago c. 2011;27(21):2957\u201363.","journal-title":"Tanja Mago c"},{"issue":"16","key":"2081_CR22","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27(16):2194\u2013200.","journal-title":"Bioinformatics"},{"issue":"6","key":"2081_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1530\/EJE-13-0039","volume":"168","author":"D Panidis","year":"2013","unstructured":"Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, et al. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome. Eur J Endocrinol. 2013;168(6):871\u20137.","journal-title":"Eur J Endocrinol"},{"key":"2081_CR24","doi-asserted-by":"publisher","unstructured":"Chang RJ, Dumesic DA. Polycystic Ovary Syndrome and Hyperandrogenic States [Internet]. Eighth Edi. Yen & Jaffe\u2019s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth Edition. Elsevier Inc.; 2019. 520\u2013555.e13 p. Available from: https:\/\/doi.org\/10.1016\/B978-0-323-47912-7.00021-4.","DOI":"10.1016\/B978-0-323-47912-7.00021-4"},{"key":"2081_CR25","doi-asserted-by":"crossref","unstructured":"Patel J, Chaudhary H, Panchal S, Rajput K, Joshi R. Investigating the impact of phthalate exposure on endocrine function in women with polycystic ovary syndrome. BMC Endocr Disord. 2026.","DOI":"10.1186\/s12902-026-02166-5"},{"issue":"12","key":"2081_CR26","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","volume":"86","author":"VL Nelson","year":"2001","unstructured":"Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(12):5925\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"2081_CR27","doi-asserted-by":"publisher","first-page":"201279","DOI":"10.1016\/j.humgen.2024.201279","volume":"40","author":"H Gene","year":"2024","unstructured":"Gene H, Chaudhary H, Patel J, Jain NK, Panchal S, Laddha N. Investigating the interplay between AMH gene polymorphism rs10407022 and clinical indicators in polycystic ovary syndrome. Hum Gene. 2024;40(January):201279. Available from: https:\/\/doi.org\/10.1016\/j.humgen.2024.201279.","journal-title":"Hum Gene"},{"key":"2081_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xfss.2025.03.005","author":"H Chaudhary","year":"2025","unstructured":"Chaudhary H, Ph D, Patel J, Ph D, Jain NK, Ph D et al Impact of CYP19A1 genetic variations on polycystic ovary syndrome: fi ndings from a case-control study. Fertil Steril Sci. 2025; Available from: https:\/\/doi.org\/10.1016\/j.xfss.2025.03.005.","journal-title":"Fertil Steril Sci"},{"issue":"3","key":"2081_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000521971","volume":"25","author":"MF Atoum","year":"2022","unstructured":"Atoum MF, Alajlouni MM, Alzoughool F. A case-control study of the luteinizing hormone level in luteinizing hormone receptor gene (rs2293275) polymorphism in polycystic ovarian syndrome females. Public Health Genomics. 2022;25(3):89\u201397.","journal-title":"Public Health Genomics"},{"key":"2081_CR30","doi-asserted-by":"publisher","unstructured":"Mitra\u0161inovi\u0107-Bruli\u0107 M, Buljan M, Suljevi\u0107 D Association of LH\/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome. Middle East Fertil Soc J. 2021;26(1). Available from: https:\/\/doi.org\/10.1186\/s43043-021-00085-0.","DOI":"10.1186\/s43043-021-00085-0"},{"issue":"FEB","key":"2081_CR31","first-page":"1","volume":"8","author":"R Liu","year":"2017","unstructured":"Liu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, et al. Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Front Microbiol. 2017;8(FEB):1\u201312.","journal-title":"Front Microbiol"},{"issue":"1","key":"2081_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0168390","volume":"12","author":"L Lindheim","year":"2017","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, Trummer C, Zachhuber V, Leber B, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS ONE. 2017;12(1):1\u201320.","journal-title":"PLoS ONE"},{"issue":"AUG","key":"2081_CR33","first-page":"1","volume":"7","author":"L Lindheim","year":"2016","unstructured":"Lindheim L, Bashir M, M\u00fcnzker J, Trummer C, Zachhuber V, Pieber TR, et al. The salivary microbiome in polycystic ovary syndrome (PCOS) and its association with disease-related parameters: a pilot study. Front Microbiol. 2016;7(AUG):1\u201311.","journal-title":"Front Microbiol"},{"issue":"1","key":"2081_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):1\u201312. Available from: https:\/\/doi.org\/10.1186\/s13073-016-0303-2.","journal-title":"Genome Med"},{"issue":"7464","key":"2081_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"E Le Chatelier","year":"2013","unstructured":"Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541\u20136.","journal-title":"Nature"},{"issue":"1","key":"2081_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):1\u201311. Available from: https:\/\/doi.org\/10.1038\/s41467-017-00900-1.","journal-title":"Nat Commun"},{"issue":"July","key":"2081_CR37","first-page":"1","volume":"13","author":"G Li","year":"2022","unstructured":"Li G, Liu Z, Ren F, Shi H, Zhao Q, Song Y, et al. Alterations of gut microbiome and fecal fatty acids in patients with polycystic ovary syndrome in central China. Front Microbiol. 2022;13(July):1\u201312.","journal-title":"Front Microbiol"},{"issue":"March","key":"2081_CR38","first-page":"1","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Liu Y, Li X. Effects of intestinal flora on polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14(March):1\u20139.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2081_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/EC-19-0522","volume":"9","author":"L Zhou","year":"2020","unstructured":"Zhou L, Ni Z, Cheng W, Yu J, Sun S, Zhai D, et al. Characteristic gut microbiota and predicted metabolic functions in women with PCOS. Endocr Connect. 2020;9(1):63\u201373.","journal-title":"Endocr Connect"},{"issue":"1","key":"2081_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","volume":"170","author":"B Zeng","year":"2019","unstructured":"Zeng B, Lai Z, Sun L, Zhang Z, Yang J, Li Z et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study. Res Microbiol. 2019;170(1):43\u201352. Available from: https:\/\/doi.org\/10.1016\/j.resmic.2018.09.002.","journal-title":"Res Microbiol"},{"issue":"2","key":"2081_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ismej.2010.133","volume":"5","author":"C Lozupone","year":"2011","unstructured":"Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R, UniFrac. An effective distance metric for microbial community comparison. ISME J. 2011;5(2):169\u201372. Available from: https:\/\/doi.org\/10.1038\/ismej.2010.133.","journal-title":"ISME J"},{"issue":"4","key":"2081_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324\u201335. Available from: https:\/\/doi.org\/10.1016\/j.chom.2011.10.003.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"2081_CR43","first-page":"1","volume":"108","author":"M Kwa","year":"2016","unstructured":"Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016;108(8):1\u201310.","journal-title":"J Natl Cancer Inst"},{"issue":"4-5","key":"2081_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.resmic.2019.03.003","volume":"170","author":"JH Shin","year":"2019","unstructured":"Shin JH, Park YH, Sim M, Kim SA, Joung H, Shin DM Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome. Res Microbiol. 2019;170(4\u20135):192\u2013201. Available from: https:\/\/doi.org\/10.1016\/j.resmic.2019.03.003.","journal-title":"Res Microbiol"},{"issue":"3","key":"2081_CR45","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1210\/clinem\/dgaa848","volume":"106","author":"K L\u00fcll","year":"2021","unstructured":"L\u00fcll K, Arffman RK, Sola-Leyva A, Molina NM, Aasmets O, Herzig KH, et al. The gut microbiome in polycystic ovary syndrome and its association with metabolic traits. J Clin Endocrinol Metab. 2021;106(3):858\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"2081_CR46","doi-asserted-by":"publisher","unstructured":"Tremellen K, Pearce K. Dysbiosis of Gut Microbiota (DOGMA) - A novel theory for the development of polycystic ovarian syndrome. Med Hypotheses [Internet]. 2012;79(1):104\u201312. Available from: https:\/\/doi.org\/10.1016\/j.mehy.2012.04.016.","DOI":"10.1016\/j.mehy.2012.04.016"},{"key":"2081_CR47","doi-asserted-by":"crossref","unstructured":"Guo J, Shao J, Yang Y, Niu X, Liao J, Zhao Q et al. Gut microbiota in patients with polycystic ovary syndrome: a systematic review. 2021.","DOI":"10.1007\/s43032-020-00430-0"},{"issue":"7402","key":"2081_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"C Huttenhower","year":"2012","unstructured":"Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT et al Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207\u201314. Available from: https:\/\/doi.org\/10.1038\/nature11234.","journal-title":"Nature"},{"issue":"1","key":"2081_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1371\/journal.pone.0146509","volume":"11","author":"ST Kelley","year":"2016","unstructured":"Kelley ST, Skarra DV, Rivera AJ, Thackray VG. The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome. PLoS ONE. 2016;11(1):4\u20136.","journal-title":"PLoS ONE"},{"key":"2081_CR50","doi-asserted-by":"publisher","unstructured":"Chu W, Han Q, Xu J, Wang J, Sun Y, Li W et al. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome. Fertil Steril . 2020;113(6):1286\u20131298.e4. Available from: https:\/\/doi.org\/10.1016\/j.fertnstert.2020.01.027.","DOI":"10.1016\/j.fertnstert.2020.01.027"},{"issue":"November","key":"2081_CR51","first-page":"1","volume":"11","author":"K Nie","year":"2021","unstructured":"Nie K, Ma K, Luo W, Shen Z, Yang Z, Xiao M, et al. Roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species. Front Cell Infect Microbiol. 2021;11(November):1\u201315.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2081_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2019.11.001","volume":"27","author":"B Seo","year":"2020","unstructured":"Seo B, Jeon K, Moon S, Lee K, Kim WK, Jeong H et al Roseburia spp. abundance associates with alcohol consumption in humans and its administration ameliorates alcoholic fatty liver in mice. Cell Host Microbe. 2020;27(1):25\u201340.e6. Available from: https:\/\/doi.org\/10.1016\/j.chom.2019.11.001.","journal-title":"Cell Host Microbe"},{"issue":"February","key":"2081_CR53","first-page":"1","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gao S, Ye C, Zhao W. Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol. 2023;13(February):1\u20137.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2081_CR54","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y et al Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225\u201333. Available from: https:\/\/doi.org\/10.1038\/s41591-019-0509-0.","journal-title":"Nat Med"},{"key":"2081_CR55","doi-asserted-by":"crossref","unstructured":"Li C, Cheng D, Ren H, Zhang T. Unraveling the gut microbiota \u2019 s role in PCOS: a new frontier in metabolic health. 2025;(March):1\u201311.","DOI":"10.3389\/fendo.2025.1529703"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02081-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02081-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:00:29Z","timestamp":1779231629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02081-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02081-2","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Each study participant provided written informed consent before enrollment. The study was approved by the Gujarat University Institutional Ethics Committee (IEC) (Non-Interventional) with reference number (GU-IEC(NIV)\/02\/Ph.D.\/007) and conducted in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}